Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxacin in ALS
NCT04840823Phase 2Completed
- Sponsor
- McGill University
- Start
- Mar 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enoxacin in amyotrophic lateral sclerosis (ALS), sponsored by McGill University. Started Mar 2021; status: completed.
02
Drugs
enoxacin
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT04840823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04840823.